Literature DB >> 27406587

Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.

Irena Srebotnik-Kirbiš1, Clara Limbäck-Stokin2.   

Abstract

Currently, oligodendroglial tumours (OT) are routinely tested for 1p/19q codeletion, a genetic abnormality of prognostic value. This analysis is most commonly performed by fluorescence in situ hybridization (FISH) on formalin-fixed, paraffin embedded (FFPE) tissue sections, which is time-consuming and often difficult to interpret, mainly due to the presence of truncated and overlapping nuclei. To overcome these methodological disadvantages, we investigated the validity of cytospins prepared from brushings of fresh tissue samples for assessing 1p/19q status by FISH. For this purpose, FISH analysis of 1p/19q codeletion was performed on FFPE tissue sections and cytospins prepared from brushing of corresponding fresh tissue in a series of 35 central nervous system tumours (16 OT and 19 non-OT). An aberrant 1p/19q status was found in 11/16 (69 %) OT samples and included codeletion of 1p/19q (7), 1p/19q imbalance (2) isolated 19q deletion (1) and 1p imbalance (1). None of the 19 non-OT samples showed 1p/19q codeletion. Results of FISH were concordant between FFPE sections and cytospins in all cases in which both types of slides gave interpretable results. Interpretation of FISH signals on cytospins was easier and quicker than on FFPE sections. Our study showed that cytospins prepared from brushing of fresh tissue samples allow quick and reliable FISH based analysis of 1p/19q status and can substitute traditional FFPE sections when fresh tissue is available.

Entities:  

Keywords:  1p/19q codeletion; Brush cytology; Fluorescence in situ hybridization (FISH); Oligodendroglioma

Mesh:

Year:  2016        PMID: 27406587     DOI: 10.1007/s11060-016-2211-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

Review 1.  Molecular diagnostics: techniques and recommendations for 1p/19q assessment.

Authors:  Adelheid Woehrer; Johannes A Hainfellner
Journal:  CNS Oncol       Date:  2015-11-06

2.  Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.

Authors:  Felix Sahm; David Reuss; Christian Koelsche; David Capper; Jens Schittenhelm; Stephanie Heim; David T W Jones; Stefan M Pfister; Christel Herold-Mende; Wolfgang Wick; Wolf Mueller; Christian Hartmann; Werner Paulus; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2014-08-21       Impact factor: 17.088

3.  Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines.

Authors:  P F Ambros; I M Ambros
Journal:  Med Pediatr Oncol       Date:  2001-12

4.  FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma.

Authors:  Matteo Brunelli; Diego Segala; Brett Delahunt; Claudia Parolini; Samantha Bersani; Liang Cheng; John N Eble; Marco Chilosi; Stefano Gobbo; Guido Martignoni
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

5.  ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.

Authors:  David E Reuss; Felix Sahm; Daniel Schrimpf; Benedikt Wiestler; David Capper; Christian Koelsche; Leonille Schweizer; Andrey Korshunov; David T W Jones; Volker Hovestadt; Michel Mittelbronn; Jens Schittenhelm; Christel Herold-Mende; Andreas Unterberg; Michael Platten; Michael Weller; Wolfgang Wick; Stefan M Pfister; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2014-11-27       Impact factor: 17.088

6.  High-level detection of gene amplification and chromosome aneuploidy in extracted nuclei from paraffin-embedded tissue of human cancer using FISH: a new approach for retrospective studies.

Authors:  E Rossi; A Ubiali; P Balzarini; M Cadei; F Alpi; P G Grigolatoi
Journal:  Eur J Histochem       Date:  2005 Jan-Mar       Impact factor: 3.188

7.  IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.

Authors:  Adriana Olar; Khalida M Wani; Kristin D Alfaro-Munoz; Lindsey E Heathcock; Hinke F van Thuijl; Mark R Gilbert; Terri S Armstrong; Erik P Sulman; Daniel P Cahill; Elizabeth Vera-Bolanos; Ying Yuan; Jaap C Reijneveld; Bauke Ylstra; Pieter Wesseling; Kenneth D Aldape
Journal:  Acta Neuropathol       Date:  2015-02-21       Impact factor: 17.088

8.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Authors:  Gregory Cairncross; Meihua Wang; Edward Shaw; Robert Jenkins; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperriere; Walter Curran; Minesh Mehta
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

9.  Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies.

Authors:  Corinne Bouvier; Patrice Roll; Benoit Quilichini; Philippe Metellus; Arlette Calisti; Sophie Gilles; Olivier Chinot; Frederic Fina; Pierre M Martin; Dominique Figarella-Branger
Journal:  J Neurooncol       Date:  2004-06       Impact factor: 4.130

10.  Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors.

Authors:  Marc C Chamberlain; Donald Born
Journal:  J Neurooncol       Date:  2015-09-04       Impact factor: 4.130

View more
  4 in total

Review 1.  Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.

Authors:  Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Sebastian Brandner; Luke Vale; Julian Pt Higgins; Kathreena M Kurian
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

2.  Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status.

Authors:  Chiara Pesenti; Leda Paganini; Laura Fontana; Emanuela Veniani; Letterio Runza; Stefano Ferrero; Silvano Bosari; Maura Menghi; Giovanni Marfia; Manuela Caroli; Rosamaria Silipigni; Silvana Guerneri; Silvia Tabano; Monica Miozzo
Journal:  Oncotarget       Date:  2017-07-08

Review 3.  Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.

Authors:  Sebastian Brandner; Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Luke Vale; Julian P T Higgins; Kathreena M Kurian
Journal:  Neuropathol Appl Neurobiol       Date:  2022-03-03       Impact factor: 6.250

4.  Application of Intelligent Ultrasound in Real-Time Monitoring of Postoperative Analgesic Nerve Block.

Authors:  Zhengwei Li; Ling Zhao; Wutao Wang; Ling Zheng
Journal:  Contrast Media Mol Imaging       Date:  2021-12-09       Impact factor: 3.161

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.